https://www.selleckchem.com/pr....oducts/3-deazaneplan
61, p = .058, Cramer's V = .147). Among those with ARFID, DGBI presence was associated with the fear of aversive consequences prototype and multiple comorbid prototype presence. We demonstrated notable overlap between DGBI and EDs, particularly post-prandial distress symptoms. Further research is needed to examine if gastrointestinal symptoms predict or are a result of greater ED pathology, including ARFID prototypes. We demonstrated notable overlap between DGBI and EDs, particularly post-prandial distress symptoms. Fu
إعجاب
علق
شارك
